ARTICLE | Clinical News
Ixmyelocel-T: Phase IIb data
March 21, 2016 7:00 AM UTC
Top-line data from the double-blind, U.S. Phase IIb ixCELL-DCM trial in 114 patients with advanced heart failure due to ischemic DCM showed that 12-20 transendocardial catheter-based injections of 0.4...